Analyst firms · Citigroup · ILMN

Citigroup ILMN price target and rating history

Illumina Inc. (ILMN) · Health Care

Citigroup rates Illumina Inc. (ILMN) Neutral with a $90 price target, as of its latest action on Mar 4, 2025. It has published 5 rating actions on ILMN since December 2022, including 2 upgrades and 2 downgrades. Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.

Current rating
Neutral
Price target
$90
Median target, all firms
$185
Actions on ILMN
5

Citigroup price target on ILMN

$180$135$902023202420252026
Citigroup price target on ILMN, each point a stated target, December 2022 to March 2025.

Every Citigroup rating on ILMN

How other firms rate ILMN

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
StephensEqual-Weight$275Oct 23, 2026
UBSBuy$260Sep 9, 2026
BernsteinMkt Perform$185Jun 26, 2026
RBC Capital MarketsOutperform$170May 15, 2026
DaiwaOutperform$155May 14, 2026

Questions about Citigroup and ILMN

What is Citigroup's price target for ILMN?
Citigroup's latest stated price target for Illumina Inc. (ILMN) is $90, from its action on Mar 4, 2025.
What is Citigroup's rating on ILMN?
Citigroup rates ILMN Neutral, a neutral rating, as of Mar 4, 2025.
When did Citigroup last change its view on ILMN?
On Mar 4, 2025, Citigroup cuts its price target to $90 from $130, keeps Neutral.
How does Citigroup's ILMN target compare with other analysts?
Across 5 firms with a ILMN price target in the last 12 months, the median target is $185.

More ILMN rating histories

All Citigroup ratingsILMN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.